A Day Up For Gossamer Bio, Inc.
Mon, Jul 27, 2026 at 07:38 PM
Gossamer Bio, Inc. (GOSS:NASDAQ) jumped higher at $0.2, a gain of 46.6%. On Mon, Jul 27, 2026, GOSS:NASDAQ hit a New 2-Week High of $0.2. The stock appeared on our News Catalysts scanner on Mon, Jul 27, 2026 at 12:01 PM in the 'BIOTECH' category. From Mon, Jul 13, 2026, the stock recorded 40.00% Up Days and 45.45% Green Days
About Gossamer Bio, Inc. (GOSS:NASDAQ)
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its pipeline products include GB001 (DP2 Antagonist), GB002 (PDGF Receptor Kinase Inhibitor), GB004 (HIF-1a Stabilizer), and others.
Top 10 Gainers:
- T3 Defense Inc Com New (DFNS:NASDAQ), 201.15%
- Baiya International Group Inc. (BIYA:NASDAQ), 116.06%
- Entera Bio Ltd. (ENTX:NASDAQ), 91.22%
- LiveWire Group, Inc. (LVWR:NYSE), 66.44%
- Gossamer Bio, Inc. (GOSS:NASDAQ), 46.62%
- The9 Limited (NCTY:NASDAQ), 41.43%
- Forte Biosciences, Inc. (FBRX:NASDAQ), 39.65%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 37.53%
- NIP Group Inc. (NIPG:NASDAQ), 28.26%
- Skycorp Solar Group Ltd (PN:NASDAQ), 27.07%